Spanish Menopause Society position statement: use of tibolone in postmenopausal women

作者：Mendoza Nicolas^*; Abad Pedro; Baro Francesc; Jesus Cancelo Ma; Llaneza Placido; Manubens Montserrat; Quereda Francisco; Sanchez Borrego Rafael

来源：Menopause-The Journal of the North American Menopause Society, 2013, 20(7): 754-760.

DOI：10.1097/gme.0b013e31827b18c5

• Tibolone
• Postmenopausal
• Hormone therapy

Tibolone is a drug with complex tissue-specific action that exhibits a combination of estrogenic, progestogenic, and slight androgenic activity. Its variable profile explains its clinical effects, depending on the target tissue where it is metabolized, its metabolites%26apos; affinity for and potency in hormone receptors, and probable enzymatic activity modulation. In recent reviews and clinical trials, the effectiveness of tibolone in alleviating different hot flush menopause symptoms, mainly in mood and sexuality disorders, has been noted. In Spain, tibolone is the most prescribed hormonal treatment, and one of the most common complaints among postmenopausal women is change in sexual drive. For such reason, a panel of experts from the Spanish Menopause Society met to develop usage recommendations based on the best evidence available.

• 出版日期2013-7